Back to
Avoro Capital Advisors LLC
TNGX
Showing 2 of 12 quarters
Position history for
Avoro Capital Advisors LLC's holdings in TANGO THERAPEUTICS INC
No. Avoro Capital Advisors exited its TNGX (Tango Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 545,000 shares worth $4.6M. Avoro Capital Advisors already held TNGX in its Q3 2021 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.6M
Total Shares Change
-545,000
Quarter-by-Quarter History